​

argenx SE (ARGX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ARGX Stock Forecast

argenx SE (ARGX) stock forecast, based on 33 Wall Street analysts, predicts a 12-month average price target of $697.00, with a high of $715.00 and a low of $680.00. This represents a 10.72% increase from the last price of $629.51.

$350 $430 $510 $590 $670 $750 High: $715 Avg: $697 Low: $680 Last Closed Price: $629.51

ARGX Stock Rating

argenx SE stock's rating consensus is Buy, based on 33 Wall Street analysts. The breakdown includes 1 Strong Buy (3.03%), 28 Buy (84.85%), 4 Hold (12.12%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 33 4 28 1 Strong Sell Sell Hold Buy Strong Buy

ARGX Price Target Upside V Benchmarks

TypeNameUpside
Stockargenx SE10.72%
SectorHealthcare Stocks 30.37%
IndustryBiotech Stocks 73.37%

Price Target Trends

1M3M12M
# Anlaysts-116
Avg Price Target-$680.00$545.25
Last Closing Price$629.51$629.51$629.51
Upside/Downside-8.02%-13.39%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 257132--22
Mar, 257132--22
Feb, 257132--22
Jan, 257132--22
Dec, 247142--23
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 04, 2025Robert W. Baird$680.00$621.259.46%8.02%
Jan 14, 2025Jason ButlerJMP Securities$696.00$648.627.30%10.56%
Nov 05, 2024George FarmerScotiabank$715.00$602.4718.68%13.58%
Oct 10, 2024Danielle BrillRaymond James$605.00$520.5216.23%-3.89%
Jul 29, 2024Joel BeattyRobert W. Baird$515.00$495.923.85%-18.19%
Jul 26, 2024Douglas TsaoH.C. Wainwright$533.00$492.078.32%-15.33%
Jul 23, 2024Leland GershellOppenheimer$546.00$461.0118.44%-13.27%
Jul 22, 2024Joon LeeTruist Financial$540.00$461.0117.13%-14.22%
Jul 12, 2024Gavin Clark-GartnerEvercore ISI$533.00$461.7215.44%-15.33%
Jun 26, 2024Douglas TsaoH.C. Wainwright$490.00$451.558.52%-22.16%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 12, 2025Deutsche BankHoldHoldupgrade
Feb 28, 2025OppenheimerOutperformOutperformhold
Feb 28, 2025CitigroupOutperformOutperformhold
Jan 14, 2025H.C. WainwrightBuyBuyhold
Jan 14, 2025JMP SecuritiesOutperformOutperformhold
Dec 19, 2024Wells FargoOverweightOverweighthold
Dec 09, 2024Piper SandlerOverweightOverweighthold
Nov 22, 2024JefferiesBuyBuyhold
Nov 11, 2024Wolfe ResearchOutperformupgrade
Nov 05, 2024ScotiabankSector PerformOutperformupgrade

Financial Forecast

EPS Forecast

$-20 $-7 $6 $19 $32 $45 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.01$-7.99$-13.05$-5.16-----
Avg Forecast$-10.20$-6.93$-13.84$-4.27$2.19$9.99$18.54$26.94$34.47
High Forecast$-9.02$-6.13$-10.14$-3.65$3.24$17.75$35.69$34.50$42.05
Low Forecast$-12.34$-8.38$-16.90$-6.65$0.91$3.87$7.41$13.79$24.60
Surprise %-99.90%15.30%-5.71%20.84%-----

Revenue Forecast

$0 $2B $3B $5B $6B $8B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$44.80M$497.28M$410.75M$1.23B-----
Avg Forecast$71.20M$510.21M$441.26M$1.21B$2.17B$3.32B$4.40B$5.38B$6.49B
High Forecast$82.66M$592.33M$516.41M$1.22B$2.20B$3.80B$4.52B$5.54B$7.58B
Low Forecast$64.86M$464.78M$350.58M$1.18B$2.14B$2.82B$4.28B$5.21B$5.06B
Surprise %-37.08%-2.54%-6.92%1.38%-----

Net Income Forecast

$-1B $-300M $400M $1B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-650.55M$-408.26M$-709.59M$-295.05M-----
Avg Forecast$-583.25M$-396.15M$-173.12M$-268.11M$118.49M$647.04M$1.30B$1.79B$1.97B
High Forecast$-515.74M$-350.29M$-54.70M$-84.72M$185.18M$1.01B$2.04B$1.97B$2.40B
Low Forecast$-705.29M$-479.04M$-291.53M$-451.51M$51.81M$221.00M$423.47M$788.32M$1.41B
Surprise %11.54%3.06%309.90%10.05%-----

ARGX Forecast FAQ

Is argenx SE stock a buy?

argenx SE stock has a consensus rating of Buy, based on 33 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 28 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that argenx SE is a favorable investment for most analysts.

What is argenx SE's price target?

argenx SE's price target, set by 33 Wall Street analysts, averages $697 over the next 12 months. The price target range spans from $680 at the low end to $715 at the high end, suggesting a potential 10.72% change from the previous closing price of $629.51.

How does argenx SE stock forecast compare to its benchmarks?

argenx SE's stock forecast shows a 10.72% upside, underperforming the average forecast for the healthcare stocks sector (30.37%) and underperforming the biotech stocks industry (73.37%).

What is the breakdown of analyst ratings for argenx SE over the past three months?

  • April 2025: 31.82% Strong Buy, 59.09% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 31.82% Strong Buy, 59.09% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 31.82% Strong Buy, 59.09% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.

What is argenx SE’s EPS forecast?

argenx SE's average annual EPS forecast for its fiscal year ending in December 2024 is $2.19, marking a -142.44% decrease from the reported $-5.16 in 2023. Estimates for the following years are $9.99 in 2025, $18.54 in 2026, $26.94 in 2027, and $34.47 in 2028.

What is argenx SE’s revenue forecast?

argenx SE's average annual revenue forecast for its fiscal year ending in December 2024 is $2.17B, reflecting a 76.93% increase from the reported $1.23B in 2023. The forecast for 2025 is $3.32B, followed by $4.4B for 2026, $5.38B for 2027, and $6.49B for 2028.

What is argenx SE’s net income forecast?

argenx SE's net income forecast for the fiscal year ending in December 2024 stands at $118.49M, representing a -140.16% decrease from the reported $-295M in 2023. Projections indicate $647.04M in 2025, $1.3B in 2026, $1.79B in 2027, and $1.97B in 2028.